Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.
DD, BHF, TGNA, CTVA, FISV, SNAP, BMY, QSR, HOLX, CMCSA, T, ELAN, ATVI, LH, GE, NLOK, FE, XRX
CSCO, CHKP, CBOE, J, OTIS, IEX, CMI, PFE
KLAC, TROW, COP, PINS, MDC, BMY
Damien Conover, CFASector Director